1190222-97-9

Basic information

• Product Name: 4-(3-nitrophenyl)-1H-pyrazole
• Synonyms: 4-(3-nitrophenyl)-1H-pyrazole
• CAS NO: 1190222-97-9
• Molecular Weight: 189.173
• Mol File: 1190222-97-9.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 4-(3-nitrophenyl)-1H-pyrazole(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-nitrophenyl)-1H-pyrazole(1190222-97-9)
• EPA Substance Registry System: 4-(3-nitrophenyl)-1H-pyrazole(1190222-97-9)

Safety Data

• Hazardous Substances Data: 1190222-97-9(Hazardous Substances Data)

Upstream product

• 552846-17-0 tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate 
• 585-79-5 m-nitrobromobenzene 

Downstream Products

• 1170691-45-8 3-(1H-pyrazol-4-yl)aniline 
• 1190223-01-8 phosphoric acid di-tert-butyl [4-(3-nitrophenyl)-1H-pyrazol-1-yl]methyl ester 
• 1190222-96-8 4-(3-nitrophenyl)-1H-pyrazole-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF

The present invention relates to a Rho-associated protein kinase inhibitor of Formula (I), a pharmaceutical composition comprising the same, a preparation method thereof, and use thereof for the prevention or treatment of a disease mediated by the Rho-associated protein kinase (ROCK).

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.